Study Stopped
Initially the study failed to start due to Covid concerns. As this is an immunocompromised patient population, this concern has persisted and study initiation was further complicated by a demographic and availability change in research team members.
Exercise in Dialysis
Assessing the Impact of Intra-dialytic Exercise Regimen on Depression Scores
1 other identifier
interventional
N/A
1 country
2
Brief Summary
The purpose of the proposed clinical trial is to support intradialytic pedal cycling exercise as an intervention and show its effect on depression and how there is a need for more programs to support this. This is an exploratory single arm study. These patients will be cycling during dialysis treatment by using a graded duration model. Even though patients on hemodialysis (HD) have an increased life span due to renal replacement therapy, exercise can have a remarkable effect on their ability to perform daily activities. Dialysis has been shown to reduce self-confidence, increase social isolation, and cause feelings of disappointment in the future. This population faces mental and psychological stress due to the disease burden. Short-term supervised cycling programs while patients are receiving dialysis have been reported to induce systematic improvements for depression and anxiety. Exercise during hemodialysis is an effective way to reduce depressive symptoms without using pharmacologic measures. Data for each patient will be collected at each dialysis treatment using a unique patient identifier. The data that will be collected include duration of exercise (intermittent or continuous), any complications during HD, vital signs while cycling every 30 minutes, and how they state they feel after cycling. The measurable outcome will be depression scores. The tool that will be used for this project is the Beck Depression Inventory (BDI). The patient will complete the BDI assessment on week 1 (pre intervention as baseline) and then on week 10 (post intervention).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2024
Shorter than P25 for not_applicable depression
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 9, 2021
CompletedStudy Start
First participant enrolled
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2024
CompletedFebruary 12, 2024
February 1, 2024
1 month
December 1, 2021
February 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Beck Depression Inventory (BDI) Score
BDI is a 21-item self-report scale designed to measure the severity of depressive symptoms. Each item is scored 0-3. The total score range is 0-63; the higher the score, the more severe the depression. A score \> 40 indicates extreme depression.
Week 1, Week 10
Study Arms (1)
Hemodialysis Patients
EXPERIMENTALInterventions
The intervention will be that the patient cycles in a sitting position within the first 2 hours of hemodialysis treatment for 15-60 minutes/as tolerated, either intermittent/continuous duration. - Graded duration will increase every 2 weeks. This will be supervised by a dialysis nurse as per the schedule of study assessments.
Eligibility Criteria
You may qualify if:
- greater than 18 years of age
- male or female
- ESKD on maintenance hemodialysis for 3 consecutive months
- adequate dialysis clearances (Kt/V greater than 1.2),
- able to participate in exercise program based on nephrologist evaluation
- able to provide written informed consent for participation,
- Compliance with dialysis treatment regimen (attended 75% of ordered dialysis treatments in the last 3 months.
You may not qualify if:
- less than 18 years old
- on hemodialysis for \< 3 consecutive months
- acute Kidney Injury diagnosis
- patients deemed clinically unstable by Nephrologist
- active foot ulcer
- unable to provide written consent
- refusal of participation
- lower limb amputations
- patients with dementia or severe cognitive impairment
- patients with Psychiatric disorders (who are not treated and unstable)
- pregnancy
- myocardial infarction in the last 6 months
- uncontrolled diabetes
- patients on chronic Midodrine therapy for intradialytic blood pressure support.
- deep vein thrombosis
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
NYU Dialysis Center of Bethpage
Bethpage, New York, 11714, United States
NYU Winthrop Dialysis Center - Outpatient
Mineola, New York, 11501, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naveed Masani, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2021
First Posted
December 9, 2021
Study Start
February 2, 2024
Primary Completion
March 11, 2024
Study Completion
May 20, 2024
Last Updated
February 12, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Naveed.Masani@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.